Vikram Deshpande

57.4k total citations · 13 hit papers
329 papers, 21.5k citations indexed

About

Vikram Deshpande is a scholar working on Surgery, Oncology and Rheumatology. According to data from OpenAlex, Vikram Deshpande has authored 329 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Surgery, 131 papers in Oncology and 106 papers in Rheumatology. Recurrent topics in Vikram Deshpande's work include IgG4-Related and Inflammatory Diseases (81 papers), Neuroendocrine Tumor Research Advances (77 papers) and Pancreatic and Hepatic Oncology Research (67 papers). Vikram Deshpande is often cited by papers focused on IgG4-Related and Inflammatory Diseases (81 papers), Neuroendocrine Tumor Research Advances (77 papers) and Pancreatic and Hepatic Oncology Research (67 papers). Vikram Deshpande collaborates with scholars based in United States, United Kingdom and Japan. Vikram Deshpande's co-authors include John H. Stone, Yoh Zen, Arezou Khosroshahi, Gregory Y. Lauwers, Mollie N. Carruthers, Zachary S. Wallace, Mari Mino–Kenudson, G. Petur Nielsen, Shiv Pillai and Vinay S. Mahajan and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Vikram Deshpande

319 papers receiving 21.1k citations

Hit Papers

IgG4-Related Disease 2010 2026 2015 2020 2012 2015 2011 2012 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IgG4-Related Disease
    2012 1.8k citations Vikram Deshpande et al. profile →
  2. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
    2015 615 citations Vikram Deshpande, Nabeel Bardeesy et al. profile →
  3. Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
    2011 548 citations Kenneth K. Tanabe, Aram F. Hezel et al. profile →
  4. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake
    2012 547 citations Ömer Yılmaz, G. Petur Nielsen et al. profile →
  5. IgG4-Related Disease
    2013 504 citations Vikram Deshpande et al. profile →
  6. Rituximab for IgG4-related disease: a prospective, open-label trial
    2015 444 citations Vikram Deshpande et al. profile →
  7. IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients
    2015 431 citations Vikram Deshpande et al. profile →
  8. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4‐related systemic disease
    2010 402 citations Vikram Deshpande et al. profile →
  9. Stromal response to Hedgehog signaling restrains pancreatic cancer progression
    2014 386 citations Vikram Deshpande, Nabeel Bardeesy et al. profile →
  10. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease
    2014 373 citations Vikram Deshpande et al. profile →
  11. Rituximab for the Treatment of IgG4-Related Disease
    2011 350 citations Vikram Deshpande et al. profile →
  12. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
    2014 316 citations Vikram Deshpande et al. profile →
  13. SOX17 enables immune evasion of early colorectal adenomas and cancers
    2024 47 citations Vikram Deshpande et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikram Deshpande United States 76 9.5k 9.4k 8.4k 5.9k 5.0k 329 21.5k
Yoh Zen Japan 70 8.9k 0.9× 10.6k 1.1× 8.6k 1.0× 4.0k 0.7× 3.4k 0.7× 358 19.5k
Kazuichi Okazaki Japan 67 9.6k 1.0× 11.0k 1.2× 7.1k 0.8× 2.6k 0.4× 2.9k 0.6× 448 17.3k
Jason L. Hornick United States 82 7.0k 0.7× 5.1k 0.5× 3.0k 0.4× 8.3k 1.4× 4.5k 0.9× 487 24.8k
Günter Klöppel Germany 92 2.6k 0.3× 13.1k 1.4× 13.1k 1.6× 19.7k 3.3× 5.9k 1.2× 457 30.6k
Jae Y. Ro United States 83 4.3k 0.5× 7.7k 0.8× 2.1k 0.3× 7.6k 1.3× 6.6k 1.3× 595 24.2k
Masazumi Tsuneyoshi Japan 74 3.5k 0.4× 6.0k 0.6× 2.0k 0.2× 7.6k 1.3× 6.2k 1.2× 577 22.3k
Raf Sciot Belgium 81 5.7k 0.6× 4.6k 0.5× 1.7k 0.2× 5.2k 0.9× 4.6k 0.9× 555 24.8k
John R. Goldblum United States 79 4.7k 0.5× 9.7k 1.0× 2.6k 0.3× 5.7k 1.0× 2.0k 0.4× 362 22.7k
Yoshinao Oda Japan 64 2.3k 0.2× 4.4k 0.5× 1.9k 0.2× 8.7k 1.5× 6.3k 1.3× 948 20.4k
W. Glenn McCluggage United Kingdom 70 1.7k 0.2× 4.5k 0.5× 3.3k 0.4× 2.9k 0.5× 3.1k 0.6× 549 17.5k

Countries citing papers authored by Vikram Deshpande

Since Specialization
Citations

This map shows the geographic impact of Vikram Deshpande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Deshpande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Deshpande more than expected).

Fields of papers citing papers by Vikram Deshpande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Deshpande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Deshpande. The network helps show where Vikram Deshpande may publish in the future.

Co-authorship network of co-authors of Vikram Deshpande

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram Deshpande. A scholar is included among the top collaborators of Vikram Deshpande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram Deshpande. Vikram Deshpande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deshpande, Vikram, Sanjay A Pai, & Benjamin L. Mazer. (2025). WHO is embedding inequality into cancer diagnostics. PubMed. 4(1). e000889–e000889.
2.
Nielsen, Mathias I., Justina C. Wolters, Hua Jiang, et al.. (2025). Targeted detection of endogenous LINE-1 proteins and ORF2p interactions. Mobile DNA. 16(1). 3–3. 1 indexed citations
3.
Rickelt, Steffen, David T. Ting, Cristina R. Ferrone, et al.. (2024). β2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma. American Journal of Clinical Pathology. 162(5). 500–508. 1 indexed citations
4.
Devins, Kyle M., Wesley Samore, G. Petur Nielsen, Vikram Deshpande, & Esther Oliva. (2023). Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors. Modern Pathology. 36(6). 100143–100143. 13 indexed citations
5.
Raabe, Michael J., Chenyue Lu, Vikram Deshpande, et al.. (2023). Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD. Blood. 142(21). 1831–1844.
6.
Deschênes‐Simard, Xavier, Stéphane Lopes‐Paciencia, Benjamin Le Calvé, et al.. (2023). Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer. Cell Cycle. 22(19). 2172–2193. 8 indexed citations
7.
Neyaz, Azfar, Steffen Rickelt, Ömer Yılmaz, et al.. (2023). Quantitative p53 immunostaining aids in the detection of prevalent dysplasia. Journal of Clinical Pathology. 76(9). 582–590. 1 indexed citations
8.
Neyaz, Azfar, Steffen Rickelt, M. Lisa Zhang, et al.. (2022). Defining an abnormal p53 immunohistochemical stain in Barrett's oesophagus‐related dysplasia: a single‐positive crypt is a sensitive and specific marker of dysplasia. Histopathology. 82(4). 555–566. 4 indexed citations
9.
Yılmaz, Osman, Azfar Neyaz, Soo Hyun Lee, et al.. (2022). Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon. Histopathology. 81(3). 380–388. 5 indexed citations
10.
Javed, Ammar A., Alessandra Pulvirenti, Jian Zheng, et al.. (2022). A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study. Surgery. 172(6). 1800–1806. 7 indexed citations
11.
Birnbaum, David Jérémie, Pascal Finetti, Charles Vanderburg, et al.. (2021). Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 27(8). 2314–2325. 11 indexed citations
12.
Rickelt, Steffen, Miyeko Mana, Charles A. Whittaker, et al.. (2019). Agrin in the Muscularis Mucosa Serves as a Biomarker Distinguishing Hyperplastic Polyps from Sessile Serrated Lesions. Clinical Cancer Research. 26(6). 1277–1287. 11 indexed citations
13.
Stagner, Anna M., Dipti P. Sajed, G. Petur Nielsen, et al.. (2019). Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern. The American Journal of Surgical Pathology. 43(6). 819–826. 9 indexed citations
14.
Cai, Lei, Theodoros Michelakos, Vikram Deshpande, et al.. (2019). Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs). Clinical Cancer Research. 25(8). 2644–2655. 60 indexed citations
15.
Saylor, Philip J., Richard J. Lee, Kshitij S. Arora, et al.. (2016). Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 23(2). 363–369. 22 indexed citations
16.
Sabbatino, Francesco, Vincenzo Villani, Jennifer H. Yearley, et al.. (2015). PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma. Clinical Cancer Research. 22(2). 470–478. 162 indexed citations
17.
Alagesan, Brinda, Gianmarco Contino, Alexander R. Guimarães, et al.. (2014). Combined MEK and PI3K Inhibition in a Mouse Model of Pancreatic Cancer. Clinical Cancer Research. 21(2). 396–404. 103 indexed citations
18.
Hezel, Aram F., Vikram Deshpande, Stephanie M. Zimmerman, et al.. (2012). TGF-β and αvβ6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression. Cancer Research. 72(18). 4840–4845. 77 indexed citations
19.
Corcoran, Ryan B., Gianmarco Contino, Vikram Deshpande, et al.. (2011). STAT3 Plays a Critical Role in KRAS -Induced Pancreatic Tumorigenesis. Cancer Research. 71(14). 5020–5029. 334 indexed citations
20.
Deshpande, Vikram, Mari Mino–Kenudson, William R. Brugge, & Gregory Y. Lauwers. (2005). Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology.. PubMed. 129(9). 1148–54. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoh Zen Breakdown of academic impact, for papers by Kazuichi Okazaki Breakdown of academic impact, for papers by Jason L. Hornick Breakdown of academic impact, for papers by Günter Klöppel Breakdown of academic impact, for papers by Jae Y. Ro Breakdown of academic impact, for papers by Masazumi Tsuneyoshi Breakdown of academic impact, for papers by Raf Sciot Breakdown of academic impact, for papers by John R. Goldblum Breakdown of academic impact, for papers by Yoshinao Oda Breakdown of academic impact, for papers by W. Glenn McCluggage
Rankless by CCL
2026